Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hutchmed China Ltd (13 HK)
Watchlist
177
Analysis
Industrials
•
Hong Kong
HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hutchmed China Ltd
•
07 Aug 2024 08:55
Hutchmed China Ltd (13.HK/HCM.US) 24H1 - Fruquintinib's US Sales Beat; Break-Even Is Within Reach
HUTCHMED's fruquintinib US sales and savolitinib combination with osimertinib for NSCLC will drive future growth. Breakeven in 2025 is expected...
Xinyao (Criss) Wang
Follow
218 Views
Share
bullish
•
Hutchmed China Ltd
•
02 Aug 2024 18:35
•
Broker
Hutchmed (13 HK) - Fruquintinib’s Overseas Sales Beat
HCM’s oncology/immunology product revenue reached US$128mn in 1H24 (+59.6% YoY), including US$43mn revenue recognised from fruquintinib’s sales...
CMB International
Follow
344 Views
Share
bullish
•
Hutchmed China Ltd
•
19 Jun 2024 08:55
Hutchmed China Ltd (13.HK/HCM.US) - Time to Reassess Valuation Prospects Despite the Pain Points
HUTCHMED’s 2024 full-year sales may once again exceed expectations. It's time to recalculate the peak sales of pipeline and the Company’s outlook....
Xinyao (Criss) Wang
Follow
210 Views
Share
bullish
•
Hutchmed China Ltd
•
12 Mar 2024 08:55
Hutchmed China Ltd (13.HK/HCM.US) - High Growth Is Expected from 2024 to 2026
HUTCHMED will enter a period of accelerated growth in product revenue based on major catalysts in 2024 to 2026. Global sales of fruquintinib will...
Xinyao (Criss) Wang
Follow
386 Views
Share
bullish
•
Hutchmed China Ltd
•
01 Mar 2024 19:54
•
Broker
Hutchmed (13 HK) – A Fruitful 2024 on the Way
Including US$312mn upfront and milestone payments from Takeda, HCM’s consolidated revenues from oncology/immunology reached US$529mn in FY23
CMB International
Follow
344 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x